FMR LLC 13D and 13G filings for The Oncology Institute, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 11:50 am Sale | 2024-11-29 | 13G | The Oncology Institute, Inc. TOI | FMR LLC | 0 0.000% | -4,754,083 (Position Closed) | Filing |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | The Oncology Institute, Inc. TOI | FMR LLC | 4,754,083 6.309% | -7,247,899 (-60.39%) | Filing |
| 2023-02-09 12:01 pm Purchase | 2023-02-09 | 13G | The Oncology Institute, Inc. TOI | FMR LLC | 12,001,982 16.590% | 1,982 (+0.02%) | Filing |
| 2021-12-10 08:52 am Purchase | 2021-12-09 | 13G | The Oncology Institute, Inc. TOI | FMR LLC | 12,000,000 12.467% | 12,000,000 (New Position) | Filing |